share_log

BRIEF-Acrux Says Us FDA Accepted For Review Co's Abbreviated New Drug Application

reuters ·  Sep 12, 2021 22:49

Sept 13 (Reuters) - Acrux Ltd  ACR.AX :

* US FOOD AND DRUG ADMINISTRATION HAS ACCEPTED FOR REVIEW CO'S ABBREVIATED NEW DRUG APPLICATION FOR ITS GENERIC VERSION OF DAPSONE GEL, 5%

Source text for Eikon:  ID:nASXvtvrV  Further company coverage:  ACR.AX

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment